TickerFacts.

A business in context

VRTX research notebook

Read the disclosures. Follow the relationships. Keep the dates in view.

Research JSON

Filing timeline

Download filings CSV

SEC submissions · retrieved 2026-09-07 · 8010 issuers; up to 32 recent company reports and 8 ownership-change filings per issuer

  1. 4 · Ownership change

    Report date 2026-08-28 · 0000875320-26-000267

  2. 8-K · Current report

    Report date 2026-08-27 · 0000875320-26-000264 · Items 5.02

  3. 4 · Ownership change

    Report date 2026-08-27 · 0000875320-26-000261

  4. 10-Q · Quarterly report

    Report date 2026-06-30 · 0000875320-26-000259

  5. 8-K · Current report

    Report date 2026-08-03 · 0000875320-26-000256 · Items 2.02,9.01

  6. 4 · Ownership change

    Report date 2026-07-21 · 0000875320-26-000253

  7. 4 · Ownership change

    Report date 2026-07-21 · 0000875320-26-000251

  8. 4 · Ownership change

    Report date 2026-07-15 · 0000875320-26-000249

  9. 4 · Ownership change

    Report date 2026-07-15 · 0000875320-26-000247

  10. 8-K · Current report

    Report date 2026-07-06 · 0001193125-26-296710 · Items 1.01,7.01,8.01,9.01

  11. 4 · Ownership change

    Report date 2026-07-02 · 0000875320-26-000245

  12. 4 · Ownership change

    Report date 2026-07-02 · 0000875320-26-000243

  13. 8-K · Current report

    Report date 2026-05-13 · 0000875320-26-000204 · Items 5.02,5.07

  14. 10-Q · Quarterly report

    Report date 2026-03-31 · 0000875320-26-000173

  15. 8-K · Current report

    Report date 2026-05-04 · 0000875320-26-000171 · Items 2.02,9.01

  16. 8-K · Current report

    Report date 2026-04-28 · 0000875320-26-000166 · Items 5.02

  17. DEF 14A · Proxy statement

    Report date 2026-05-13 · 0000875320-26-000153

  18. 8-K · Current report

    Report date 2026-03-31 · 0000875320-26-000147 · Items 8.01

  19. 10-K · Annual report

    Report date 2025-12-31 · 0000875320-26-000056

  20. 8-K · Current report

    Report date 2026-02-12 · 0000875320-26-000034 · Items 2.02,9.01

  21. 10-Q · Quarterly report

    Report date 2025-09-30 · 0000875320-25-000232

  22. 8-K · Current report

    Report date 2025-11-03 · 0000875320-25-000230 · Items 2.02,9.01

  23. 10-Q · Quarterly report

    Report date 2025-06-30 · 0000875320-25-000216

  24. 8-K · Current report

    Report date 2025-08-04 · 0000875320-25-000213 · Items 2.02,5.02,9.01

  25. 8-K · Current report

    Report date 2025-05-19 · 0000875320-25-000199 · Items 8.01

  26. 8-K · Current report

    Report date 2025-05-14 · 0000875320-25-000194 · Items 5.07

  27. 10-Q · Quarterly report

    Report date 2025-03-31 · 0000875320-25-000192

  28. 8-K · Current report

    Report date 2025-05-05 · 0000875320-25-000171 · Items 2.02,9.01

  29. DEF 14A · Proxy statement

    Report date 2025-05-14 · 0000875320-25-000160

  30. 8-K · Current report

    Report date 2025-03-28 · 0000875320-25-000156 · Items 8.01

  31. 10-K · Annual report

    Report date 2024-12-31 · 0000875320-25-000053

  32. 8-K · Current report

    Report date 2025-02-04 · 0000875320-25-000029 · Items 2.02,5.02,9.01

  33. 8-K · Current report

    Report date 2024-12-20 · 0000875320-24-000231 · Items 7.01

  34. 10-Q · Quarterly report

    Report date 2024-09-30 · 0000875320-24-000223

  35. 8-K · Current report

    Report date 2024-11-04 · 0000875320-24-000221 · Items 2.02,9.01

  36. 8-K · Current report

    Report date 2024-08-15 · 0000875320-24-000207 · Items 1.01

  37. 10-Q · Quarterly report

    Report date 2024-06-30 · 0000875320-24-000198

  38. 8-K · Current report

    Report date 2024-08-01 · 0000875320-24-000193 · Items 2.02,9.01

  39. 8-K · Current report

    Report date 2024-06-27 · 0000875320-24-000178 · Items 8.01

  40. 8-K · Current report

    Report date 2024-05-20 · 0001193125-24-142278 · Items 8.01,9.01

Reported insider transactions

Download transactions CSV

SEC insider transactions · retrieved 2026-09-07 · 2026 Q2: filings in this completed quarter; not a live transaction feed

Purchases and sales include open-market or private transactions. Grants, exercises and tax withholding are shown separately. Amendments and joint reports can overlap; rows are not a net-buying score. Prices retain the filing's units; consult its footnotes.

Transaction rows by code · counts, not monetary totals
Purchase: 0 transaction rows0PSale: 12 transaction rows12SGrant / award: 19 transaction rows19AExercise / conversion: 0 transaction rows0MTax / exercise payment: 0 transaction rows0FGift: 0 transaction rows0G
P · PurchaseS · SaleA · Grant / awardM · Exercise / conversionF · Tax / exercise paymentG · Gift

35 matching transaction rows.

Transaction / filedReporting ownerTypeSecuritySharesReported price
2026-06-26
2026-06-30
Bozic Carmen
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock596.0482.5
2026-06-18
2026-06-23
Bozic Carmen
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock1020.0462.17
2026-06-15
2026-06-17
Bozic Carmen
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock4062.0450.0
2026-06-05
2026-06-09
Bozic Carmen
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock1745.0450.0
2026-06-01
2026-06-03
Liu Joy
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock828.0439.91
2026-05-29
2026-06-02
Bozic Carmen
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock1974.0450.0
2026-05-15
2026-05-19
Bunnage Mark E.
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock33.0453.45
2026-05-15
2026-05-19
Bozic Carmen
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock1354.0453.45
2026-05-12
2026-05-14
Bozic Carmen
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock6988.0450.0
2026-05-04
2026-05-05
Bhatia Sangeeta N.
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock318.0423.73
2026-05-01
2026-05-05
Upadhyay SuketuD · Disposition to issuer
Disposed
Common Stock796.0—
2026-05-01
2026-05-05
Upadhyay SuketuA · Grant / award
Acquired
Stock Option (Right to Buy)
Derivative security
2866.00.0
2026-05-01
2026-05-05
Upadhyay SuketuA · Grant / award
Acquired
Deferred Stock Units
Derivative security
796.0—
2026-05-01
2026-05-05
Thornberry NancyA · Grant / award
Acquired
Common Stock472.00.0
2026-05-01
2026-05-05
Thornberry NancyD · Disposition to issuer
Disposed
Common Stock398.0—
2026-05-01
2026-05-05
Thornberry NancyA · Grant / award
Acquired
Deferred Stock Units
Derivative security
398.0—
2026-05-01
2026-05-05
Thornberry NancyA · Grant / award
Acquired
Stock Option (Right to Buy)
Derivative security
1433.00.0
2026-05-01
2026-05-05
Schneider JenniferD · Disposition to issuer
Disposed
Common Stock796.0—
2026-05-01
2026-05-05
Schneider JenniferA · Grant / award
Acquired
Common Stock472.00.0
2026-05-01
2026-05-05
Schneider JenniferA · Grant / award
Acquired
Stock Option (Right to Buy)
Derivative security
1433.00.0
2026-05-01
2026-05-05
Schneider JenniferA · Grant / award
Acquired
Deferred Stock Units
Derivative security
796.0—
2026-05-01
2026-05-05
SACHS BRUCE IA · Grant / award
Acquired
Stock Option (Right to Buy)
Derivative security
2866.00.0
2026-05-01
2026-05-05
MCKENZIE DIANAD · Disposition to issuer
Disposed
Common Stock796.0—
2026-05-01
2026-05-05
MCKENZIE DIANAA · Grant / award
Acquired
Common Stock943.00.0
2026-05-01
2026-05-05
MCKENZIE DIANAA · Grant / award
Acquired
Deferred Stock Units
Derivative security
796.0—
2026-05-01
2026-05-05
Liu Joy
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock1104.0425.02
2026-05-01
2026-05-05
Lagarde MichelA · Grant / award
Acquired
Stock Option (Right to Buy)
Derivative security
2866.00.0
2026-05-01
2026-05-05
Garber Alan MA · Grant / award
Acquired
Common Stock472.00.0
2026-05-01
2026-05-05
Garber Alan MA · Grant / award
Acquired
Stock Option (Right to Buy)
Derivative security
1433.00.0
2026-05-01
2026-05-05
CARNEY LLOYDA · Grant / award
Acquired
Stock Option (Right to Buy)
Derivative security
2866.00.0
2026-05-01
2026-05-05
Bhatia Sangeeta N.
10b5-1 checkbox reported
A · Grant / award
Acquired
Common Stock943.00.0
2026-04-15
2026-04-17
Upadhyay SuketuA · Grant / award
Acquired
Deferred Stock Units
Derivative security
80.51442.5
2026-04-15
2026-04-17
SACHS BRUCE IA · Grant / award
Acquired
Deferred Stock Units
Derivative security
107.35442.5
2026-04-15
2026-04-17
Garber Alan MA · Grant / award
Acquired
Deferred Stock Units
Derivative security
33.9442.5
2026-04-01
2026-04-03
Liu Joy
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock978.0449.17

Identity & relationships

Wikidata structured data · retrieved 2026-09-07 · 1611 unambiguous CIK-linked entities; coverage is incomplete

These are sourced identity and relationship claims, with incomplete coverage. Headquarters locations do not describe sales, assets or operating exposure.

SEC issuer · 0000875320VERTEX PHARMACEUTICALS INC / MA
Vertex Pharmaceuticals (United Kingdom)

Showing 1 of 1 imported Wikidata subsidiary claims. Additional aliases appear below.

No parent relationship is available in this import; this is not proof of independence.

No verified LEI join available.

GLEIF legal entity reference data · retrieved 2026-09-07 · 1177 checked identities; 0 unavailable records

Search names and former names

View Wikidata identity and references ↗

  • Vertex Pharmaceuticals · alias · wikidata
  • Vertex Pharmaceuticals Inc. · alias · wikidata
  • Vertex · alias · wikidata
  • Vertex Pharmaceuticals (United Kingdom) · subsidiary · wikidata
Explore headquarters map ↗

Revenue in constant purchasing power

USD revenue expressed in 2026-07 consumer-price dollars. Each annual period uses a CPI-U average weighted by the days in its actual reporting interval. This is a purchasing-power comparison, not a company-specific price or volume measure.

Year endedReported USD revenueCPI-adjusted USD revenue
2024-12-31$11.02B$11.73B
2023-12-31$9.87B$10.81B
2022-12-31$8.93B$10.19B
2021-12-31$7.57B$9.33B
2020-12-31$6.21B$8.01B
2019-12-31$4.16B$5.44B
2018-12-31$3.05B$4.05B
2017-12-31$2.49B$3.39B

Bureau of Labor Statistics · retrieved 2026-09-07 · 9 selected series; gaps remain missing

Explore the CPI history ↗